SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Behavioral Neurology Referral — Frederick Law Olmsted — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.
| Patient | Frederick Law Olmsted |
|---|
| Date of birth | 1822-04-26 |
|---|
| Identifiers | MRN HR-NI022-SYN-TD; SSN (made up) 000-22-5519 |
|---|
| Document date | 1895-05-05 |
|---|
| Author | Nathan Calder, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Reason for Referral
Progressive memory loss over about two years in a 73-year-old landscape architect who has had to step back from his practice. Please confirm whether this is dementia or mild cognitive impairment, advise on the likely type and on biomarker testing, advise on treatment, and advise on driving. [S]
Urgency: Routine, within four weeks, on the same day as his results visit. [S]
Questions for the consultant:
- Does he meet criteria for dementia rather than mild cognitive impairment, and at what stage?
- What type of dementia is most likely, and do the MRI findings point to one?
- Would blood, CSF, or amyloid PET biomarkers help, and is he a candidate for anti-amyloid therapy?
- Do you recommend a cholinesterase inhibitor, and with what monitoring?
- Is it safe for him to keep driving, and what other safety steps do you advise?
- How often should he be followed, and by whom?
History of Present Illness
About two years of worsening memory: repeats questions, loses track of letters and project plans, misses appointments without reminders; he stepped back from his practice this year because of it. History from him and his caregiver. MoCA 19 of 30, losing points on delayed recall (1 of 5), orientation to date, clock drawing, trail-making, and fluency. Katz ADL 6 of 6; Lawton IADL 5 of 8 (help with finances, medicines, and travel planning). NPI-Q: mild irritability and apathy. PHQ-9 6, without thoughts of self-harm. Timed Up and Go 11 seconds; no falls; normal gait. Blood count, metabolic panel, albumin, ALT, vitamin B12 410 pg/mL, folate, and TSH 1.9 all normal; syphilis and HIV not tested, as he has no risk factors. MRI of the brain two weeks after the first visit: generalized cortical atrophy beyond that expected for age, mild bilateral medial temporal atrophy (MTA score 2), and Fazekas grade 1 white-matter change, without infarct, mass, or hydrocephalus. No medicines. Still driving short familiar routes. No firearms at home. Pulse 72 and blood pressure 134/78 mmHg at the first visit [S]
- He is frustrated that he can no longer keep the details of his projects in mind and wants to understand what is happening. [S]
- His caregiver wants to keep him safe at home and needs help and information. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
- Frederick Law Olmsted was born in Hartford, Connecticut, on April 26, 1822. [D]
- Olmsted ceased active practice in 1895, a victim of failing memory and vitality; later accounts say dementia, or senility, forced his retirement, and his sons took over the firm. [D]
- Olmsted, who had chosen the Belmont site of McLean Hospital in 1872, was admitted there as a patient at the end of his life and spent his last five years there, until his death in 1903. [D]
- His McLean Hospital medical record is sealed, and the cause of his decline is not known. [D]
- Any specific type of dementia (for example Alzheimer's disease or vascular dementia) is a retrospective interpretation; the cited sources say only failing memory, senility, and dementia. [R]
- A psychiatrist has argued retrospectively that losses in his childhood, beginning with his mother's death when he was a young child, left him with post-traumatic stress, and that his late illness made it worse. [R]
- In 1863, exhausted and ill after overwork as head of the U.S. Sanitary Commission, Olmsted resigned. [D]
2 later historical claims are omitted because they describe events after the index age. See the teaching note.
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Progressive memory loss over about two years with decline in managing his work and affairs, under evaluation for dementia or mild cognitive impairment | active | confirmed |
R41.3 | S — Synthetic presenting concern at the index visit, superseded by the dementia diagnosis at the four-week visit; the failing memory is documented (D). |
Past Medical History
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|
| 1863 | Exhaustion and illness from overwork while leading a national wartime relief commission, ending in his resignation in 1863; illness not specified in the cited source | D (CLM-0009) |
Family History
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
Social History
- Never used tobacco; one glass of wine with dinner a few nights a week, stopped at the first visit on advice; no other drug use [S]
- Landscape architect who stepped back from his practice this year because of his memory; lives at home with family, and a primary caregiver who is not named in this record accompanies him to visits [S]
- Walks in the garden and the neighborhood most days with company [S]
- Drove locally at the first visit; no firearms in the home [S]
- Supports: his primary caregiver, family at home, long-time colleagues who visit, and a lifelong love of gardens and walking [S]
Vital Signs
| Date | Measure | Value | Unit | Provenance |
| 1895-05-05 | Body height | 175 | cm | S |
| 1895-05-05 | Body weight | 72 | kg | S |
| 1895-05-05 | Body mass index (BMI) [Ratio] | 23.5 | kg/m2 | S |
| 1895-05-05 | Systolic blood pressure | 134 | mm[Hg] | S |
| 1895-05-05 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1895-05-05 | Heart rate | 72 | /min | S |
| 1895-05-05 | Respiratory rate | 14 | /min | S |
| 1895-05-05 | Body temperature | 36.7 | Cel | S |
| 1895-05-05 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 1895-05-05 | Hemoglobin [Mass/volume] in Blood | 14.1 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 1895-05-05 | Leukocytes [#/volume] in Blood by Automated count | 6.2 | 10*3/uL | 3.4-9.6 10*3/uL | Normal | S |
| 1895-05-05 | Platelets [#/volume] in Blood by Automated count | 238 | 10*3/uL | 135-317 10*3/uL | Normal | S |
| 1895-05-05 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1895-05-05 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1895-05-05 | Creatinine [Mass/volume] in Serum or Plasma | 1.02 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1895-05-05 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1890)/1.73 sq M | 76 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1895-05-05 | Glucose [Mass/volume] in Serum or Plasma | 94 | mg/dL | 70-99 mg/dL | Normal | S |
| 1895-05-05 | Calcium [Mass/volume] in Serum or Plasma | 9.4 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 1895-05-05 | Albumin [Mass/volume] in Serum or Plasma | 4.1 | g/dL | 3.5-5 g/dL | Normal | S |
| 1895-05-05 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 22 | U/L | 7-55 U/L | Normal | S |
| 1895-05-05 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 410 | pg/mL | 232-1245 pg/mL | Normal | S |
| 1895-05-05 | Folate [Mass/volume] in Serum or Plasma | 12.4 | ng/mL | >=5.9 ng/mL | Normal | S |
| 1895-05-05 | Thyrotropin [Units/volume] in Serum or Plasma | 1.9 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 1895-05-05 | Total score [MoCA] | 19 | {score} | | | S |
| 1895-05-05 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | | | S |
Assessment
- Progressive memory loss over about two years with decline in managing his work and affairs, under evaluation for dementia or mild cognitive impairment: active, confirmed [S]
Plan of Treatment
- Reversible-cause tests (blood count, metabolic panel, vitamin B12, folate, TSH) and one non-contrast brain MRI; syphilis and HIV testing only with risk factors or atypical features. Guideline: Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology (2001); Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for primary care (2025); CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Alzheimer's disease monographs (2026) [S]
- Caregiver support: Zarit Burden Interview at diagnosis and every six to twelve months, education, adult day program and respite, and Alzheimer's Association support services. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for primary care (2025); CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Alzheimer's disease monographs (2026) [S]
- Monitor on the CMID dementia schedule: medication review and neuropsychiatric screen at every visit; MoCA, ADL and IADL, CDR or FAST stage, depression screen, fall risk, driving, and advance care planning yearly; repeat tests or imaging only with a sudden change. Guideline: CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Alzheimer's disease monographs (2026) [S]
- Advance care planning while he can take part: name a health care agent and record his values and wishes. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for primary care (2025); CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Alzheimer's disease monographs (2026) [S]
- Referral to behavioral neurology, Marguerite Osei, MD, ordered 1895-05-05 [S]